Identification and characterization of a new metallo-β-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 8, 2007, Pages 2988-2990

  Perilli, Mariagrazia ^a   Caporale, Bibiana ^a   Celenza, Giuseppe ^a   Pellegrini, Cristina ^a   Docquier, Jean Denis ^b   Mezzatesta, Marilina ^c   Rossolini, Gian Maria ^b   Stefani, A ^c   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; LATAMOXEF; MEROPENEM; METALLO BETA LACTAMASE; NITROCEFIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHRYSEOBACTERIUM INDOLOGENES; DRUG HYDROLYSIS; ENZYME ANALYSIS; ENZYME KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINS; CHRYSEOBACTERIUM; FLAVOBACTERIACEAE INFECTIONS; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENICILLINS; SEQUENCE ANALYSIS, DNA;

EID: 34547616857     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00083-07     Document Type: Article

References (12)

1. Bellais, S., L. Poirel, S. Leotard, T. Naas, and P. Nordmann. 2000. Genetic diversity of carbapenem-hydrolyzing metallo-β-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob. Agents Chemother. 44: 3028-3034.
2. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
3. De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frere, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases. Biochem. Pharmacol. 36:2393-2403.
4. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (London) 227:680-685.
5. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.
6. Perilli, M., A. Felici, N. Franceschini, A. De Santis, L. Pagani, F. Luzzaro, A. Oratore, G. M. Rossolini, J. R. Knox, and G. Amicosante. 1997. Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain. Antimicrob. Agents Chemother. 41:2374-2382.
7. Prosperi-Meys, C., G. Llabres, D. de Seny, R. P. Soto, M. H. Valladares, N. Laraki, J. M. Frère, and M. Galleni. 1999. Interaction between class B β-lactamases and suicide substrates of active-site serine β-lactamases. FEBS Lett. 443:109-111.
8. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
9. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
10. Schreckenberger, P. C., M. I. Daneshvar, R. S. Weyant, and D. G. Hollis. 2003. Acinetobacter, Achromobacter, Cryseobacterium, Moraxella, and other nonfermentative gram-negative rods, p. 749-779. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, DC.
11. Segel, I. H. 1975. Enzyme kinetics, behavior and analysis of rapid equilibrium and steady-state enzyme systems, p. 210-212. John Wiley & Sons, Inc., New York, NY.
12. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.